Alere is the global leader in near-patient diagnostics for cardiology, infectious disease, and toxicology, with expanding capabilities in diabetes, has now launched the US FDA approved pregnancy test kit ‘Clearblue Plus’.

Internationally acclaimed Clearblue brand, which is the gold standard in Home Pregnancy, and ovulation testing, is a new age technology in home pregnancy testing, which gives results that are over 99 per cent accurate.

Developed according to the requirements of the new age woman, Clearblue PLUS gives accurate results in easy to read format as Plus (+) for pregnant and Minus (-) for not pregnant, in the most convenient and hygienic way.

Ergonomically designed Clearblue plus pregnancy test offers a longer, curved stick with an improved grip and a wide absorbent tip for ease in targeting the urine stream. A larger result window and clearer result lines make the test even easier to read.

Clinical studies with Clearblue plus pregnancy test have revealed that 56 per cent of women received a 'Pregnant' result four days early, 88 per cent of women three days early, 97 per cent of women two days early and 98 per cent of women one day early. It can be stored at room temperature doing away with the need for refrigeration and ensuring privacy.

Also, Alere’s Clearblue PLUS, is so sensitive that it can detect the pregnancy hormone hCG or the human Chorionic Gonadotrophin in urine at any time of the day.

The product has been launched across the country and will be priced at Rs. 100.

Clearblue Plus is imported from abroad through the JV partners, SPD based in Geneva. Worldwide Clearblue Plus holds the distinction of the world’s largest selling brand by volume and value. Alere is also likely to launch other products from its Clearblue portfolio in the Indian market.